title: Linear morphea and leg length discrepancy: treatment with a leg-lengthening procedure.
abstract: A 15-year-old Colombian boy with a 10-year history of linear morphea presented to a pediatric orthopedic clinic with a leg length discrepancy. The morphea had been previously treated with methotrexate, oral and topical steroids, and topical vitamin D, but the lesion persisted, extending down the entire medial aspect of the left leg across the popliteal fossa. The patient had atrophy and growth retardation of the left leg, resulting in lower extremity bone and joint pain and a 3-cm limb length disparity at maturity. The patient preferred left tibial lengthening to improve the limb length disparity.
authors.affiliation: Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, Florida.
authors.forename: Marc Z
authors.initials: MZ
authors.lastname: Handler
authors.forename: Adam J
authors.initials: AJ
authors.lastname: Wulkan
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Stricker
authors.forename: Lawrence A
authors.initials: LA
authors.lastname: Schachner
mesh_terms: D000293:Adolescent; D003879:Dermatologic Agents / Q000627:therapeutic use; D006801:Humans; D007870:Leg Length Inequality / Q000209:etiology* / Q000473:pathology / Q000601:surgery*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D019637:Orthopedic Procedures; D012594:Scleroderma, Localized / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D013256:Steroids / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
chemical_list: D003879:Dermatologic Agents; D013256:Steroids; D014815:Vitamins; D014807:Vitamin D; D008727:Methotrexate